Streetbeat News

Stock Prices

AFMD

Affimed (NASDAQ:AFMD) has received 4 analyst ratings in the last quarter, with 3 being bullish and 1 somewhat bullish. The average price target is $6.0, representing an upside from the current price of $0.5233. This average price target is a 25.0% decrease from the previous average price target of $8.00.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 7:00 pm

CRIS

Curis (NASDAQ:CRIS) has received 4 bullish ratings from analysts in the last quarter, with an average 12-month price target of $4.5, a decrease of 50.0% from the previous average price target of $9.00.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 7:00 pm

CNM

Core & Main (NYSE:CNM) has received a mix of bullish and indifferent ratings from analysts in the last quarter. The average price target is $36.57, indicating an upside from the current price of $29.825. The average price target has increased by 7.56% over the past month.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 7:00 pm

MLM

Martin Marietta Materials Inc. (NYSE:MLM) shares are currently trading at $436.62, after a 0.46% decrease. Despite a 4.83% decrease over the past month, the stock has spiked by 22.54% over the past year. The company's P/E ratio of 28.45 is slightly higher than the aggregate P/E ratio of the Construction Materials industry (28.36), suggesting that the stock may be overvalued.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 7:00 pm

ALXO

Analysts have provided mostly bullish ratings for ALX Oncology Holdings (NASDAQ:ALXO) in the last quarter. According to 6 analysts offering 12-month price targets in the last 3 months, ALX Oncology Holdings has an average price target of $16.67, representing a 45.34% decrease from the previous average price target of $30.50.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 7:00 pm

AAPL

SWKS

Skyworks Solutions Inc's stock is trading lower due to concerns over rate hikes and China's iPhone crackdown. As a supplier to Apple, Skyworks might experience a decrease in orders and revenue due to a potential ban on iPhones within sensitive Chinese government sectors. This comes amid Beijing's efforts to reduce reliance on American technology.

Portfolio Pulse from Henry Khederian

September 07, 2023 | 6:56 pm

JEWL

RIO

The rise of lab-grown diamonds is negatively impacting the natural diamond market, with Rio Tinto's stock generating lower highs. Adamas One Corp, a lab-grown diamond company, is suggested as a promising investment due to the increasing popularity and ethical appeal of lab-grown diamonds.

Portfolio Pulse from Thrash Capital

September 07, 2023 | 6:51 pm

BTCUSD

RIOT

Financial services firm Cantor Fitzgerald has identified Riot Platforms (NASDAQ:RIOT) as their top pick in the Bitcoin mining sector, setting a price target of $23.00, more than double its current price of $10.98. Despite a 19% MoM decrease in Bitcoin mining in August 2023, Riot generated $31.6 million from power credits and demand response credits. Riot's management has revised its hash rate guidance, expecting to achieve 12.5 EH/s by the end of 2023. Riot held 7,309 Bitcoin on its balance sheet as of Aug. 31, marking a 0.5% MoM increase.

Portfolio Pulse from Murtuza Merchant

September 07, 2023 | 6:50 pm

MPC

A whale investor has taken a bearish stance on Marathon Petroleum (NYSE:MPC), with 66% of the investors opening trades with bearish expectations. The whales have been targeting a price range from $65.0 to $165.0 for Marathon Petroleum over the last 3 months. The price of MPC is up 1.89% at $150.69, with RSI indicators hinting that the stock may be approaching overbought. Next earnings are expected to be released in 54 days.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 6:49 pm

PHG

Royal Philips (NYSE:PHG) has agreed to resolve all economic loss claims related to its voluntary recall of certain sleep and respiratory care devices manufactured by its subsidiary, Philips Respironics. The settlement terms, subject to court approval, include predefined cash awards for eligible participants and extended warranties on all replacement devices. Philips Respironics recorded a provision of €575 million in Q1 of 2023 to cover the estimated costs of the final settlement. Payments to class members are not expected to commence until at least Q1 2024.

Portfolio Pulse from Vandana Singh

September 07, 2023 | 6:40 pm